Remi Barbier - Cassava Sciences Chairman of the Board and Presidentident, CEO
| SAVA Stock | USD 21.19 0.08 0.38% |
Chairman
Mr. Remi Barbier is Chairman of the Board, President, Chief Executive Officer of the Company since May 1998. Mr. Barbier, the Companys founder, has served as President, Chief Executive Officer and Chairman of the Board of Directors since the Companys inception in 1998. Prior to that time, Mr. Barbier helped in the growth or founding of Exelixis Inc., a functional genomics company, ArQule, Inc., a chemistry company, and EnzyMed, Inc., a chemistry company. Mr. Barbier served as Chief Operating Officer of Exelixis, Inc. from January 1996 to May 1998. Mr. Barbier was Vice President of Corporationrationrate Development and Clinical Project Manager of XOMA Corporationrationration, or XOMA, a biotechnology company, from 1993 to 1995. Mr. Barbier is a trustee emeritus of the Carnegie Institute of Washington and the Santa Fe Institute and is on the Advisory Board of the University of California Institute for Quantitative Biosciences since 1998.
| Age | 64 |
| Tenure | 26 years |
| Professional Marks | MBA |
| Address | 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731 |
| Phone | 512 501 2444 |
| Web | https://www.cassavasciences.com |
Cassava Sciences Management Efficiency
The company has return on total asset (ROA) of (0.3427) % which means that it has lost $0.3427 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5327) %, meaning that it created substantial loss on money invested by shareholders. Cassava Sciences' management efficiency ratios could be used to measure how well Cassava Sciences manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.61. The current year's Return On Capital Employed is expected to grow to -0.73. At present, Cassava Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 7.9 M, whereas Total Assets are forecasted to decline to about 114.4 M.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Bryan Roberts | Ironwood Pharmaceuticals | 47 | |
| William Rastetter | Neurocrine Biosciences | 69 | |
| Arnold Oronsky | Dynavax Technologies | 77 | |
| Richard Pops | Alkermes Plc | 62 | |
| Jay Moorin | Eagle Pharmaceuticals | 62 | |
Management Performance
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.34 |
Cassava Sciences Leadership Team
Elected by the shareholders, the Cassava Sciences' board of directors comprises two types of representatives: Cassava Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cassava. The board's role is to monitor Cassava Sciences' management team and ensure that shareholders' interests are well served. Cassava Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cassava Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nadav Friedmann, Chief Medical and Operating Officer, Director | ||
| James MD, Chief Officer | ||
| Remi Barbier, Chairman of the Board and Presidentident, CEO | ||
| Michael Donnell, Independent Director | ||
| Michael Zamloot, Senior Operations | ||
| Michael PharmD, Senior Affairs | ||
| Robert Gussin, Independent Director | ||
| Saira Ramasastry, Independent Director | ||
| Lindsay Burns, Senior Neuroscience | ||
| Christopher Cook, Sr Counsel | ||
| Eric Schoen, Chief Officer | ||
| Nadav MD, Chief Director | ||
| Patrick Scannon, Independent Director | ||
| George Thornton, Senior Technology | ||
| Sanford Robertson, Independent Director |
Cassava Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cassava Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | 794.81 M | ||||
| Shares Outstanding | 43.25 M | ||||
| Shares Owned By Insiders | 7.17 % | ||||
| Shares Owned By Institutions | 32.71 % | ||||
| Number Of Shares Shorted | 11.79 M | ||||
| Price To Book | 7.16 X | ||||
| Gross Profit | (68.03 M) | ||||
| EBITDA | (104.43 M) |
Cassava Sciences Investors Sentiment
The influence of Cassava Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Cassava. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Cassava Sciences' public news can be used to forecast risks associated with an investment in Cassava. The trend in average sentiment can be used to explain how an investor holding Cassava can time the market purely based on public headlines and social activities around Cassava Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cassava Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cassava Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cassava Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Cassava Sciences.
Cassava Sciences Implied Volatility | 111.55 |
Cassava Sciences' implied volatility exposes the market's sentiment of Cassava Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cassava Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cassava Sciences stock will not fluctuate a lot when Cassava Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cassava Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cassava Sciences' short interest history, or implied volatility extrapolated from Cassava Sciences options trading.
Currently Active Assets on Macroaxis
When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Cassava Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.32) | Return On Assets (0.34) | Return On Equity (0.53) |
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.